Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Academics from NDM's Jenner Institute and Ludwig Institute for Cancer Research have become the latest to join the 1,900 eminent life scientists in Europe and beyond that make up the European Molecular Biology Organization (EMBO).

From left to right - Adrian Hill, Yang Shi and Ivan Ahel

Adrian Hill, Yang Shi and Ivan Ahel have been recognised for their outstanding achievements in the life sciences.

As new members of EMBO, they will help to shape the direction of life sciences, foster the careers of young researchers, and strengthen research communities in Europe and beyond.

Adrian Hill, Director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology, said:

‘I am delighted to become an EMBO member. Molecular biology has been central to my group’s research in both human genetics and, more recently, vectored vaccines. And European funding has been key to the success of the Jenner Institute and its vaccine programmes.

‘Our COVID vaccine, now widely distributed to billions of people, underscores the increasing understanding that genetically modified organisms can often be a force for good.’

Yang Shi, Professor of Epigenetics and member of the Ludwig Institute for Cancer Research, said:

‘I am honoured to be elected as an EMBO member. This is a recognition of the work my students and postdoctoral fellows have done over the past few decades.’

Ivan Ahel, E.P. Abraham Professor of Chemical Pathology at the Sir William Dunn School of Pathology, said:

‘It is a great honour to be elected as a member of EMBO. I’m excited to work with EMBO and engage in discussions and collaborations with some of the finest scientists in the field.’

Members provide guidance and support for EMBO activities, for example by evaluating funding applications, serving on EMBO Council and committees, or joining the editorial boards of EMBO Press journals.

EMBO Director Fiona Watt said:

‘The new EMBO Members and Associate Members are exceptional scientists, who carry out leading research across a variety of fields, ranging from cell biology and cancer to vaccine development and machine learning.

‘I am delighted to welcome them to EMBO, and I know that they will enrich the life of the organization immensely.’

Similar stories

Prof James Naismith elected as Academy of Medical Sciences' Vice President

Established in 1998, the Academy of Medical Sciences is one of the four UK National Academies, coordinating scholarly research activities and standards in the UK.

NDM contributes to new UK research consortium to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.

Online postgraduate diploma to tackle inequities in health research leadership

Accepting its first students in in October 2023, the Postgraduate Diploma in Global Health Research is specifically targeted at researchers and clinicians in low income countries, and will offer accessibility never previously available.

Six NDM researchers awarded full professorships

We are delighted to announce that six researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

12 NDM researchers awarded Associate Professorships

We are delighted to announce that 12 researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

New Oxford-GSK Institute to harness advanced technology and unravel mechanisms of disease

GlaxoSmithKline plc and the University of Oxford today announced a major five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine.